跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML - HSA Drug Approval Details
Approvals
/
HSA
/
MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML
Approved
THERAPEUTIC
MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML
ANFARM HELLAS S.A.
🇸🇬 Health Sciences Authority
Approval Date
Mar 17, 2025
Approval ID
15529e3d26cbc289
Company
ANFARM HELLAS S.A.
Type
Therapeutic
Approval Details
Approval Id
15529e3d26cbc289
Drug Name
MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML
Product Name
MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML
Approval Number
SIN17205P
Approval Date
2025-03-17
Registrant
PHARMAKOE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01MA14
Pharma Manufacturer Name
PHARMAKOE PTE. LTD.
Company Detail Path
/organization/pharmakoe-pte-ltd
Active Ingredients
Moxifloxacin HCl eqv Moxifloxacin
400 mg/250 ML
Moxifloxacin HCl eqv Moxifloxacin
400 mg/250 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 17, 2025
Approval ID
15529e3d26cbc289
Type
Therapeutic
Back to HSA Approvals
